Table 4

Proportion (%) of subjects with abnormal results by IBS subcategory

BiomarkerIBS-DIBS-CIBS-M
Calprotectin*13.4‡7.1‡10.9
Eosinophil protein X**12.2‡‡4.4‡‡8.0
Low growth of Bifido/Lacto***64.171.6‡‡‡64.6
Bacterial potential pathogens****75.9‡‡‡‡71.071.6
  • Across-group significance: *p=0.0025; **p<0.001; ***p=0.0402; ****p=0.0285.

  • Between-group significance, versus IBS-M: ‡p<0.004; ‡‡p<0.003; ‡‡‡p=0.0114; ‡‡‡‡p=0.0103.

  • IBS, irritable bowel syndrome.